USPTO published a patent application (US20260091127A1) for antimicrobial Janus nanoparticles with distinct hydrophobic and polycationic surfaces encapsulated in crosslinked polymers. The invention claims increased stabilization for long-term effectiveness and enhanced activity against multi-drug resistant bacteria when combined with traditional antibiotics. Inventors include Martijn Zwama, Yan Yu, Swagata Bhattacharyya, and Kunihiko Nishino.

This publication is informational for compliance and legal professionals tracking intellectual property in the antimicrobial/pharmaceutical space. No immediate regulatory action is required. Companies developing antimicrobial coatings, drug delivery systems, or antibiotic adjuvant technologies should monitor this application for potential licensing considerations or freedom-to-operate analysis.